secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immix Biopharma, Inc. (IMMX)
CIK:        0001873835
Form:       8-K/A
Filed at:   2023-03-13T23:59:59+00:00
Accession:  0001493152-23-007317
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Immix Biopharma amends 8-K to clarify no deposits at Silvergate or Silicon Valley Bank
--------------------------------------------------------------------------------

- Filing corrects original 8-K's item number from 1.01 to 7.01 for Regulation FD disclosure.
- Company confirms neither Immix nor its subsidiaries hold cash deposits or securities at Silvergate Bank or Silicon Valley Bank.
- Disclosure addresses investor concerns during the March 2023 regional banking crisis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1873835/000149315223007317/0001493152-23-007317-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1873835/000149315223007317/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-007317

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer